Business Model
Business Model
Business Model
Biophagy’s Business Model
Biophagy is managing a dual business model utilizing standard drug development programs in several therapeutic areas. It is also developing an over the counter (OTC) and/or direct to consumer (DTC) kit that will focus exclusively on autophagy stimulation and individual measurement of autophagy function over an extended period.
Proprietary Drug Discovery
- Proprietary drug discovery with newly patented compounds developed for unmet medical needs, e.g., anti-microbial, neurodegenerative diseases.
CellWatch™
- An OTC kit with a rationally designed proprietary mix designed to stimulate and measure autophagy.